Showing 1321-1330 of 2058 results for "".
Eyenovia Celebrates First FDA Approval
https://modernod.com/articles/significant-findings/eyenovia-celebrates-first-fda-approval/37736/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDry Eye Market Heating Up
https://modernod.com/articles/significant-findings/dry-eye-market-heating-up/37737/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDrug Shortages Due to Dual Indications
https://modernod.com/articles/significant-findings/drug-shortages-due-to-dual-indications/37738/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatFDA Flags Improperly Marketed Amniotic Fluid Eye Drops
https://modernod.com/articles/significant-findings/fda-flags-improperly-marketed-amniotic-fluid-eye-drops/37734/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatNew TFOS Workshop Report Available
https://modernod.com/articles/significant-findings/new-tfos-workshop-report-available/37733/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatUnderstanding Ocular Metastatic Tumors and Simulating Lesions
https://modernod.com/mod-issues/2023-apr/understanding-ocular-metastatic-tumors-and-simulating-lesions/38611/Knowing how to identify these metastases enables easy coordination of care with the patient’s oncologist or primary care provider.When Blepharitis Interferes
With Contact Lens Wearhttps://modernod.com/topics/contact-lenses/when-blepharitis-interferes-with-contact-lens-wear/38609/A review of the different types of blepharitis, how they affect the ocular surface, and what treatment options are available.The Future of Eye Examinations
https://modernod.com/topics/imagingdiagnostics/the-future-of-eye-examinations/38605/The author shares his thoughts on what factors will best set optometrists up for success in assessing patients in years to come.Scan-Based Freeform Scleral Lenses: a Review
https://modernod.com/topics/contact-lenses/scan-based-freeform-scleral-lenses-a-review/38602/Learn what these lenses are and what’s available in the category.Why You Should Be Fitting Specialty Contact Lenses
https://modernod.com/topics/contact-lenses/why-you-should-be-fitting-specialty-contact-lenses/38601/Points to ponder if you’re not already offering this option in your practice.
